/
Medicinal chemicals & botanical products company · DE · FY ends Dec · Revenue $88K · -36.82% margin
The business is unprofitable at the operating level (-27.66% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 7232.1% YoY with margins expanding 3628.1pp.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$88K
▲ +7232.1% YoY
Net Income (TTM)
-$94K
▼ -54.3% YoY
Op. Margin
-36.82%
▲ +3628.1pp YoY
ROIC
-14.28%
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$17K
▲ +66.1% YoY
Net Debt
$153K
Cash & Equiv.
$17K
3Y CAGR: +1018.2%
Continue Research